Cargando…

Population Pharmacokinetics of Vancomycin in Thai Patients

Population pharmacokinetics of vancomycin in Thai adult patients was determined by non-linear mixed-effects approach using 319 vancomycin serum concentrations from 212 patients. The data were best fitted by a two-compartment model and it was used to examine the effect of patient characteristics on t...

Descripción completa

Detalles Bibliográficos
Autores principales: Purwonugroho, Tunggul Adi, Chulavatnatol, Suvatna, Preechagoon, Yupaporn, Chindavijak, Busba, Malathum, Kumthorn, Bunuparadah, Pakwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific World Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322481/
https://www.ncbi.nlm.nih.gov/pubmed/22547995
http://dx.doi.org/10.1100/2012/762649
Descripción
Sumario:Population pharmacokinetics of vancomycin in Thai adult patients was determined by non-linear mixed-effects approach using 319 vancomycin serum concentrations from 212 patients. The data were best fitted by a two-compartment model and it was used to examine the effect of patient characteristics on the vancomycin pharmacokinetics. In the final model, there was a linear relationship between vancomycin clearance, CL (L/h), and creatinine clearance calculated by Cockcroft-Gault equation, CL(Cr) (mL/min): CL  =0.044  ×  CL(Cr). Meanwhile, volume of central compartment, V (1) (L), was linearly related with the age (years old): V (1) = 0.542  × Age. Intercompartment clearance (Q) and volume of peripheral compartment (V (2)) was 6.95 L/h and 44.2 L, respectively. The interindividual variability for CL, V (1), Q, and V (2) was 35.78, 20.93, 39.50, and 57.27%, respectively. Whereas, the intraindividual variability was 4.51 mg/L. Final model then was applied to predict serum vancomycin concentrations on validation group. Predictive performance revealed a bias of −1.43 mg/L (95% CI: −5.82–2.99) and a precision of 12.2 mg/L (95% CI: −1.60–26.16). In conclusion, population pharmacokinetic of vancomycin in Thai adult patients was developed. The model could be used to create vancomycin dosage regimen in the type of patient similar with the present study.